Verastem | VSTM - Equity Capital And Reserves

Stock Price
6.09
Daily Change
-0.44 -6.67%
Monthly
12.89%
Yearly
-13.57%
Q2 Forecast
6.44

Verastem reported $57.2M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Laboratory Of America USD 8.62B 93.2M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 648.02M 40.8M Dec/2025
Verastem USD 57.2M 72.72M Dec/2025